Shen, Michael M.

Tumor Evolution and Drug Response in Patient-Derived Organoid Models of Bladder Cancer

Lee, S. H., Hu, W., Matulay, J. T., Silva, M. V., Owczarek, T. B., Kim, K., Chua, C. W., Barlow, L. J., Kandoth, C., Williams, A. B., et al. (2018) · Cell

Bladder and Urothelial Cancer TreatmentsCancer Cells and Metastasis

Cited by 873

Identification of Causal Genetic Drivers of Human Disease through Systems-Level Analysis of Regulatory Networks

Chen, J. C., Alvarez, M. J., Talos, F., Dhruv, H., Rieckhof, G. E., Iyer, A., Diefes, K. L., Aldape, K., Berens, M., Shen, M. M., et al. (2014) · Cell

Bioinformatics and Genomic NetworksGlioma Diagnosis and Treatment

Cited by 188

Combinatorial activities of Akt and B-Raf/Erk signaling in a mouse model of androgen-independent prostate cancer.

Gao, H., Ouyang, X., Banach-Petrosky, W. A., Gerald, W. L., Shen, M. M., & Abate-Shen, C. (2006) · Proceedings of the National Academy of Sciences

Prostate Cancer Treatment and ResearchCancer, Lipids, and Metabolism

Cited by 141

HER3 Is an Actionable Target in Advanced Prostate Cancer

Gil, V., Miranda, S., Riisnaes, R., Gurel, B., D’Ambrosio, M., Vasciaveo, A., Crespo, M., Ferreira, A., Brina, D., Troiani, M., et al. (2021) · Cancer Research

Prostate Cancer Treatment and ResearchHER2/EGFR in Cancer Research

Cited by 68

Regulation of extra-embryonic endoderm stem cell differentiation by Nodal and Cripto signaling

Julio, M. K.-D., Alvarez, M. J., Galli, A., Chu, J., Price, S. M., Califano, A., & Shen, M. M. (2011) · Development

Developmental Biology and Gene RegulationPluripotent Stem Cells Research

Cited by 62

Functional redundancy of type I and type II receptors in the regulation of skeletal muscle growth by myostatin and activin A

Lee, S.-J., Lehar, A., Liu, Y., Ly, C. H., Pham, Q.-M., Michaud, M., Rydzik, R., Youngstrom, D. W., Shen, M. M., Kaartinen, V., et al. (2020) · Proceedings of the National Academy of Sciences

Muscle Physiology and DisordersTGF-β signaling in diseases

Cited by 59